Heading to Climate Week NYC? Join SOSV →

OncoPrecision

Patient-derived biology powering predictive antibody drug discovery.

Company details

OncoPrecision leverages high-throughput biology and AI/ML to build patient-centric therapeutic antibody programs. Its patient-derived, single-cell resolution models capture tumor heterogeneity without amplification, maintaining malignant clonality and immune infiltrate. The platform integrates patients throughout discovery and development to improve translational prediction of clinical outcomes in cancer. OncoPrecision is leveraging the proprietary insights generated from the platform to build a drug pipeline targeting blood and solid tumors, starting with an anti-CD64 ADC for CMML and AML.

Up to 75% of patients don’t respond to prescribed treatments. Even with best-in-class drugs only a third of patients respond.

OncoPrecision Quote Image
Tarek Ali Zaki, CEO
“Our mission is to dramatically improve cancer patient outcomes and ensure that each patient receives the best possible therapy. We envision a world where NO patient is prescribed therapy before understanding how the patient will respond to therapy.”

Get In Touch with OncoPrecision

Please tell us a little bit about yourself and why you'd like to get connected. OncoPrecision + SOSV will follow up with you via email.

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.